Hikal Limited (BOM:524735)
217.75
+4.10 (1.92%)
At close: May 26, 2026
Hikal Revenue
In the fiscal year ending March 31, 2026, Hikal had annual revenue of 17.25B INR, down -7.25%. Hikal had revenue of 5.26B in the quarter ending March 31, 2026, a decrease of -4.78%.
Revenue
17.25B
Revenue Growth
-7.25%
P/S Ratio
1.58
Revenue / Employee
8.37M
Employees
2,062
Market Cap
27.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 17.25B | -1.35B | -7.25% |
| Mar 31, 2025 | 18.60B | 752.00M | 4.21% |
| Mar 31, 2024 | 17.85B | -2.38B | -11.79% |
| Mar 31, 2023 | 20.23B | 803.09M | 4.13% |
| Mar 31, 2022 | 19.43B | 2.22B | 12.92% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.65B |
| Morepen Laboratories | 17.87B |
| Gufic Biosciences | 8.97B |
| Bliss GVS Pharma | 8.68B |
| Venus Remedies | 7.03B |
| Lincoln Pharmaceuticals | 6.52B |
| Fredun Pharmaceuticals | 5.91B |
| Syncom Formulations (India) | 5.21B |
Hikal News
- 7 hours ago - Hikal Q4 Results: Net profit falls 71% YoY to Rs 14.4 crore, revenue down 6% - Business Upturn
- 7 weeks ago - Pharma sector stocks surge sharply today, April 8: Sudeep Pharma rally 9.41%, KIMS up 5.52%, HIKAL jumps 5.30% - Business Upturn
- 3 months ago - Pharma sector stocsk today, Feb 12: Hikal jumps 13.46%, Zydus up 2.44%, Biocon rises 2.31% - Business Upturn
- 3 months ago - Hikal shares rally sharply over 10% on solid Q3 results - Business Upturn
- 6 months ago - Hikal shares rally over 12% today; Details here - Business Upturn
- 6 months ago - Hikal shares fall over 5% as company reports Q2 net loss and nearly 30% drop in sales - Business Upturn
- 6 months ago - Stocks under radar today: Titagarh Rail, Polyplex, Hikal, Maithan Alloys, NIACL and more - Business Upturn
- 8 months ago - Baba Kalyani's son retains Hikal board seat amid feud - The Times of India